Inhibiting ferroptosis: A novel approach for stroke therapeutics
Lasting results require lifestyle change, including nutrition, activity and behavior modification
Gastrointestinal symptomsincluding nausea, abdominal discomfort, bloating, and altered bowel habitsoccur because Ozempic slows gastric emptying and affects gut motility
Critical adjustment period Early months require guidance for dosing, tolerance, & progress for long-term success 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
doi: 10.1007/s40265-023-01992-4 37 ForzanoIVarzidehFAvvisatoRJankauskasSSMonePSantulliG
Oxyntomodulin acts as a dual agonist at GLP-1 and glucagon receptors, contributing to postprandial satiety while simultaneously increasing energy expenditure (Cohen et al., 2003)